Main container

Impatto del tempo di inizio del trattamento (TTI) sulla sopravvivenza nei pazienti con Osteosarcoma e Sarcoma di Ewing

Title
Impatto del tempo di inizio del trattamento (TTI) sulla sopravvivenza nei pazienti con Osteosarcoma e Sarcoma di Ewing
Code
RETRO_TTI_SARC
Type
Osservazionale
Start Year
2025
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
17/09/2025 11:39